https://www.selleckchem.com/pr....oducts/Rapamycin.htm
During the treatment and at follow-up after one month, good tolerance and no side effects were observed. Conclusions The use of benralizumab seems to be feasible, rapid, and safe in treating acute exacerbation of severe eosinophilic asthma without the use of systemic corticosteroids.The Sequence Read Archive (SRA) is a large public repository that stores raw next-generation sequencing data from thousands of diverse scientific investigations. Despite its promise, reuse and re-analysis of SRA data has been challenged by the heterogeneit
Like
Comment
Share
